The skills that make someone a great individual contributor are simply not the same skills that make someone a great leader, ...
Dr. Laws, former immunology leader at Sanofi, will oversee global development of Kymera’s KT-621 program KT-621 parallel Phase 2b trials advancing in AD and asthma, with data expected by year-end 2026 ...
Inclusion is not limited to the walls of the centre; students regularly engage with mainstream schools through visits, joint ...
When Dave Aranda is in front of a microphone at Big 12 media days, there should be plenty of questions about his quarterback, ...